GS Stays in Wait Mode as Bernstein Talk Reaffirms Crowded Bull Case Without Backlog Inflection

What happened

Goldman Sachs presented at the Bernstein conference, likely reiterating its optimistic 2026 outlook, but the DeepValue report warns that the stock at $905 already prices in a strong capital-markets cycle with limited margin of safety. Investment-banking fees rose 42% YoY in 3Q25, yet the backlog remained “essentially unchanged,” providing no forward visibility into the promised acceleration. Platform Solutions continues to be a drag, with 3Q25 provisions of $286 million and a 9M25 pre-tax loss, while the Apple Card exit is expected to generate further headline noise. Management’s narrative of a “record 2026” M&A cycle is crowded in the market, raising the risk of disappointment if fee pool conversion stalls or trading activity normalizes. The report’s WAIT rating reflects the need for tangible evidence of backlog growth and reduced platform losses before paying today’s 16.5x P/E.

Implication

Investors should remain patient: the stock’s 39% run-up over the past year has already discounted a favorable 2026 outlook, leaving little room for error. Key checkpoints in the next 90 days are 1Q26 disclosures—specifically, whether the investment-banking backlog shows sequential improvement and whether Platform Solutions provisions fall below $200 million. Without these confirmations, the crowded bull narrative could unwind, especially if trading activity decelerates further or regulatory capital requirements tighten. The attractive entry price identified is $830, offering a 8% downside from current levels, with a trim level at $1,025. For existing holders, maintaining position with a tight stop is reasonable; for new money, waiting for a better risk/reward entry is prudent.

Thesis delta

No shift in thesis: the wait stance is reinforced by the fact that the conference presentation does not alter the fundamental uncertainty around backlog conversion and platform cleanup. The stock continues to trade at a premium that requires execution proof, not just optimistic guidance. Until 1Q26 results show sequential backlog growth and declining platform losses, the risk/reward remains unfavorable for adding exposure.